Zdrowie i gospodarka · 08/11/2017

FDA Requests Public Comment on Proposed Collection of Information for Expedited Programs for Serious Conditions-Drugs and Biologics

The Food and Drug Administration (FDA) is seeking public input on a proposed information collection related to expedited programs for serious conditions, including drugs and biologics, as required by the Paperwork Reduction Act of 1995.